MYOF and neoplasm: Antitumor effects observed following myoferlin depletion have been attributed to impaired membrane repair/turnover [22], the inability to properly internalize growth factor receptors [21], impaired cancer cell motility [21, 27, 30] and the inability to sustain tumor-associated angiogenesis [20, 28].